Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Poisoning caused by sodium valproate |
Causative agent (attribute) |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental poisoning caused by sodium valproate |
Causative agent (attribute) |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional poisoning caused by sodium valproate |
Causative agent (attribute) |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by sodium valproate of undetermined intent |
Causative agent (attribute) |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate adverse reaction |
Causative agent (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Overdose of sodium valproate |
Causative agent (attribute) |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental overdose by sodium valproate |
Causative agent (attribute) |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional overdose by sodium valproate |
Causative agent (attribute) |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Overdose of sodium valproate of undetermined intent |
Causative agent (attribute) |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 400mg injection+diluent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sodium valproate in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valproate sodium 500mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valproate sodium 250mg/5mL (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
[X]Valproic acid causing adverse effects in therapeutic use |
Causative agent (attribute) |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental poisoning caused by sodium valproate |
Causative agent (attribute) |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional poisoning caused by sodium valproate |
Causative agent (attribute) |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oral sodium valproate m/r tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium valproate 100mg crushable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium valproate 200mg/5mL syrup (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium valproate 300mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium valproate 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral sodium valproate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium valproate 200mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium valproate 200mg/5mL s/f oral liquid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium valproate 200 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sodium valproate 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium valproate blood measurement |
Component |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Serum sodium valproate measurement (procedure) |
Component |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Valproate sodium 100mg/mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to valproate sodium |
Causative agent (attribute) |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sodium valproate 100mg conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sodium valproate 300 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 300 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 200 mg gastro-resistant oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 200 mg gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 500 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 500 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 200 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 200 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 400 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 400 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 40 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 40 mg/mL oral solution |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to valproate sodium |
Causative agent (attribute) |
False |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 100 mg oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 100 mg/mL solution for injection |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 100 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 133 milligram and valproic acid 58 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely sodium valproate 133 milligram and valproic acid 58 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely sodium valproate 200 milligram and valproic acid 87 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely sodium valproate 200 milligram and valproic acid 87 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sodium valproate 66.66 mg and valproic acid 29.03 mg prolonged-release oral granules sachet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sodium valproate 66.66 mg and valproic acid 29.03 mg prolonged-release oral granules sachet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sodium valproate 166.76 mg and valproic acid 72.61 mg prolonged-release oral granules sachet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sodium valproate 166.76 mg and valproic acid 72.61 mg prolonged-release oral granules sachet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely sodium valproate 1 gram/1 sachet prolonged-release oral granules (clinical drug) |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 1 gram/1 sachet prolonged-release oral granules (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 150 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 150 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 300 mg gastro-resistant oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 300 mg gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 600 mg gastro-resistant oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 600 mg gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 150 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 150 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 300 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 300 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 60 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 60 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 500 mg prolonged-release oral granules sachet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 500 mg prolonged-release oral granules sachet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 100 mg/mL solution for infusion and/or injection |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 100 mg/mL solution for infusion and/or injection |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 100 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 100 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum sodium valproate measurement (procedure) |
Component |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate blood measurement |
Component |
True |
Sodium valproate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |